Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Completed Phase 1 / 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00055770Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerTreatment